In the second financing round announced in one day for an immunometabolism startup, Johns Hopkins spinout Dracen Pharmaceuticals just wrapped up a $36 million investment deal from Deerfield.
{iframe}https://endpts.com/another-immunometabolism-deal-johns-hopkins-spinout-dracen-lands-36m-investment-from-deerfield/{/iframe}